Publication | Closed Access

The Δ32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-α and ribavirin

δ32 MutationAutoimmune DiseaseHepatologyViral HepatitisLiver PhysiologyImmunodeficienciesImmunologyMedicinePathologyHepatitisAntiviral TherapyLiver DiseaseChemokine-receptor 5Chronic Hepatitis C